Towa Pharmaceutical Co Financial Overview
Towa Pharmaceutical Co's market cap is currently $155.76B. The company's EPS TTM is ¥115.8; its P/E ratio is 7.55; and it has a dividend yield of 2.29%. Towa Pharmaceutical Co is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
